FDA
7th June 2019

Welcome To The FDA Blog At ISS!

Innovative Science Solutions (ISS) is a consulting firm with over two decades of experience in the regulatory industry.

Welcome To The FDA Blog At ISS!

Innovative Science Solutions (ISS) is a consulting firm with over two decades of experience in the regulatory industry.  As one of the leaders in regulatory submissions and drug-related FDA Advisory Committee Meeting (AdComm) support, ISS has designed this blog to give you the most up to date information on a wide array of FDA topics.  Our incredibly talented team will breakdown and provide expert insight that you won’t find anywhere else.

 

FDA Advisory Committee Meeting

  • Real-time announcements of upcoming FDA AdComm meetings
  • Direct links to meeting materials as soon as they are posted
  • Meeting outcomes and experienced commentary
  • Latest changes to the drug-related FDA AdComms, including pertinent biographical information on committee members
  • Hot topics and industry headline news that you need to know

Don’t miss the latest in FDA AdComms

 

Regulatory and Quality Standards

  • Latest industry guidance and FDA announcements for medical devices, over-the-counter Drugs, and dietary supplements
  • Recommendations for regulatory drug submissions
  • Updates on current Good Manufacturing Practices (cGMPs)
  • Project management and ISS roadmaps to success
  • Quality and manufacturing management

Be at the forefront of all industry standards

 

FDA Compliance

  • Label compliance and claim support
  • FDA common technical document
  • Case studies and warning letter analysis

A one-stop shop for your FDA compliance needs

Subscribe today so you don’t miss out. And for more custom advice on how ISS can help you, contact info@innovativescience.net

Subscribe Here !

  • This field is for validation purposes and should be left unchanged.

Recent Related Articles

Best Tips for Medical Device Manufacturers to Write a Compelling Substantial Equivalence Section for their FDA 510k Submission
01 July 2020
Best Tips for Medical Device Manufacturers to Write a Compelling Substantial Equivalence Section for their FDA 510k Submission

Over the past few years, the number of ex-US manufacturers submitting a Class II exempt 510k device registration has increased substantially. For companies with medical devices that are approved and successful in a foreign market, the logical next step is to introduce their product into the US, which has one of the most lucrative healthcare markets in the world. Read more

Evolving FDA Thinking on Advisory Committee Meetings Related to Foods, Drugs, and Devices
25 June 2020
Evolving FDA Thinking on Advisory Committee Meetings Related to Foods, Drugs, and Devices

FDA advisory committee meetings are important regulatory events for many manufacturers on the path to marketing approval. These meetings can quite literally result in the approval or rejection of a product based on the panel’s vote. Read more

NDA vs. OTC Monograph: Which Pathway is Right for You?
22 June 2020
NDA vs. OTC Monograph: Which Pathway is Right for You?

One of the main challenges our clients face is determining which regulatory pathway is best for their products. For example, what if an OTC product has a Monograph active ingredient but that ingredient is present at a different amount than the permitted amount? Or what if the label claims a novel indication not specified in a Monograph? If you are debating pursuit of either regulatory pathway for your OTC drug, it is critical to consider cost, timeline, and label claims to ensure your products has a unique stance in today’s market. Read more

4 Problems Importing Rapid Antibody Tests for Coronavirus
19 June 2020
4 Problems Importing Rapid Antibody Tests for Coronavirus

US distributors and agents trying to import rapid antibody tests for coronavirus face a number of obstacles. The good news is that FDA has opened up the Emergency Use Authorization (EUA) program to include SARS-CoV-2 (the virus) and COVID-19 (the disease), expediting time to market. Read more

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us